National Comprehensive Cancer Network Awards Champions for Excellence and Outstanding Contributions in Cancer Care

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—announces 2024 award recipients that include individuals and groups who have made significant and noteworthy impacts on improving cancer care and supporting NCCN’s mission to help all people with cancer to live better lives.

Patients at JFK University Medical Center to Benefit from $1 Million Gift from the Sarala Bathena Foundation

A $1 million gift to Hackensack Meridian JFK University Medical Center Foundation by the Sarala Bathena Foundation will establish the Sarala Bathena Oncology Patient Assistance Fund at Hackensack Meridian JFK University Medical Center, a not-for-profit medical center located in Edison, NJ.

UChicago Medicine breaks ground on $815M project to build state’s first freestanding cancer care and research pavilion

The University of Chicago Medicine broke ground Tuesday on its $815 million project to build the state’s first and only standalone structure dedicated to cancer care and research. The 575,000-square-foot, seven-story pavilion builds off UChicago’s decades of work and leadership in cancer research and its prestigious National Center Institute designation as a Comprehensive Cancer Center.

UC San Diego Health Ranks No. 1 in San Diego, Makes National Honor Roll

U.S. News & World Report ranks 10 medical and surgical specialties at UC San Diego Health among the nation’s best.

National Comprehensive Cancer Network Announces Collaboration with Blood Cancer Experts in Poland

The National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading United States cancer centers—announces a new collaboration with the Institute of Hematology and Transfusion Medicine in Poland (IHIT), and the Alliance For Innovation—Polish-American Foundation (AFI).

Jaime Merchán, M.D., Named a Translational and Clinical Oncology Research Program Co-Leader

Jaime Merchán, M.D., is the new Translational and Clinical Oncology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.

Women in Medicine: Dr. Priyamvada Rai to Co-lead Tumor Biology Research Program

Priyamvada Rai, Ph.D., is the new Tumor Biology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.

Sylvester Comprehensive Cancer Center Scientists, Collaborators Develop Powerful AI Algorithm to Gain New Insights into Deadly Glioblastoma

(MIAMI, FL, EMBARGOED UNTIL FEB. 2, 2023 AT 11 A.M. EST) — Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, collaborating with international researchers, have developed a sophisticated AI algorithm that performs advanced…

Sylvester Comprehensive Cancer Center Receives Approval to Build World-Class Myeloma Research Institute

The Myeloma Research Institute’s launch follows many important accomplishments by C. Ola Landgren, M.D., Ph.D. and his team, who are dedicated to fulfilling a promise of providing the best cancer care to myeloma patients. Florida is among the states with the highest rates of new myeloma diagnoses in the U.S., with 7.9 cases diagnosed in every 100,000 of the state’s residents.

Improving Cancer Outcomes for LGBTQ+ Patients Requires Earning Trust and Challenging Assumptions

Annual NCCN Patient Advocacy Summit explores stories and data highlighting barriers to high-quality care that LGBTQ+ people with cancer experience, examining persistent setbacks and promising developments.

Henry Ford Hospital Earns Prestigious Recognition from National Accreditation Program for Rectal Cancer

Henry Ford Hospital has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer (NAPRC), which was developed through a collaboration between the OSTRiCh (Optimizing the Surgical Treatment of Rectal Cancer) consortium and the Commission on Cancer, a quality program of the American College of Surgeons.

$1.8 Million NIH Grant Supports Head and Neck Cancer Research

Sylvester Comprehensive Cancer Center researchers Lluis Morey, Ph.D., and Ramiro Verdun, Ph.D., have received a $1.8 million NIH R01 grant to study the epigenetic mechanisms that drive head and neck cancers.

Sylvester Game Changer Vehicle Among First in Nation to Offer Mobile Prostate Cancer Screening

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine’s Game Changer vehicles, which bring health education and free screenings for many cancer types to South Florida communities in need, are for the first time offering prostate-specific antigen (PSA) screening for prostate cancer.

Sylvester Leads Study on New Treatment Option for Brain Tumor that Relapses or Fails to Respond to Standard of Care

Taken twice daily, oral olutasidenib helped to stabilize relapsed or refractory gliomas in heavily pretreated patients with less toxicity than standard of care treatment, according to a study led by Sylvester Comprehensive Cancer Center at the University of Miami School…

Sylvester Plays Pivotal Role in Practice-Changing Anal Cancer Prevention Study Published by NEJM

The New England Journal of Medicine (NEJM) has published the results of a study by Sylvester Comprehensive Cancer Center at the University of Miami Miller School and other investigators on anal cancer prevention in people living with HIV (PLHIV) that will likely establish a…

Sylvester Researchers Study Vaginal Microbiome’s Role in Screening for Endometrial Cancer

The vaginal microbiome differentiates benign disease from endometrial cancer and can even provide insight about the specific endometrial cancer type and disease severity, according to a study by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of…

Public Beware: Study Finds Potential for Massive Cancer Nutrition Misinformation on Pinterest

A multi-center team including researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine claims that the social media site Pinterest is rife with cancer misinformation. Their study found that about a third of posts…

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Launch State’s First Home Infusion Program

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have partnered with Horizon Blue Cross Blue Shield of New Jersey to launch a collaborative pilot program which provides oncology care to eligible patients in the comfort of their own home – the first of its kind in the state.

Memorial Sloan Kettering Cancer Center Appoints Tracy Gosselin as Senior Vice President, Chief Nurse Executive, and Chair of Nursing

Memorial Sloan Kettering Cancer Center (MSK) has appointed Tracy Gosselin, PhD, RN, AOCN, NEA-BC, FAAN, as Senior Vice President, Chief Nurse Executive, and Chair of Nursing effective November 2021. Dr. Gosselin currently serves as Chief Nursing & Patient Care Services Officer, Duke University Hospital.

Rutgers Faculty Receives Grant to Improve End-of-Life Cancer Care

Paul Duberstein, chair of the Department of Health Behavior, Society, and Policy at Rutgers School of Public Health and associate research member at Rutgers Cancer Institute of New Jersey, has received a New Jersey Commission on Cancer Research grant to evaluate the impact of a communication intervention that seeks to improve the care of patients with advanced cancer.

Rush University Medical Center Again on U.S. News & World Report Honor Roll

Of the more than 3,000 U.S. hospitals evaluated, Rush University Medical Center ranked No. 19 in the nation by U.S. News & World Report, with nine of specialties rated among the country’s very best.

Study of Cancer Patients and COVID-19 Highlights Health Disparities

Findings from a study led by researchers at Henry Ford Cancer Institute, in collaboration with Advocate Aurora Health, the Food and Drug Administration and Syapse®, show an elevated risk for severe COVID-19 effects or death among patients with cancer, with the highest risk being among low-income and Black patients.

Personalizing Cancer Care with Improved Tumor Models

While decades of research have resulted in substantial improvements in surviving cancer, a key challenge remains in identifying new drugs that improve outcomes for patients. In APL Bioengineering, researchers suggest a major hurdle is the paucity of models for cancer research that accurately represent patient tumors. They provide a perspective on strategies using models from individual patients and where the field needs to go in terms of research in animal systems and in culture systems.

First Report Card on Biosimilars in Oncology

SUMMARY Researchers have developed the first report card on biosimilars for three blockbuster cancer drugs marketed by Genentech/Roche: Rituxan, Avastin and Herceptin. In a Policy Review in The Lancet Oncology, Y. Tony Yang, a professor at the George Washington University…

New tools to improve care for cancer that has spread to the brain

The tools will help doctors and patients make better-informed treatment decisions, enhance the care of brain metastases, and enable hospitals to improve the coordination and effectiveness of their interdisciplinary treatment programs.

What Does it Mean to be An NCI-Designated Comprehensive Cancer Center?

Rutgers Cancer Institute is a National Cancer Institute-designated Comprehensive Cancer Center, a designation reserved for those cancer centers who meet the highest of standards in research, treatment, prevention and education. Rutgers Cancer Institute expert explains why this distinction sets Rutgers Cancer Institute and RWJBarnabas Health apart.